FDA Device Intelligence
Home › UNIVERSAL BIOSENSORS PTY LTD › Xprecia Prime™ Coagulation Analyzer

Xprecia Prime™ Coagulation Analyzer

UNIVERSAL BIOSENSORS PTY LTD · Model A0297 · UDI-DI 09360136000079

GJS Prescription
10
510(k) clearances
26,555
Adverse events (51 deaths)
73
Recalls
32
Facilities

Description

The Xprecia Prime™ Coagulation System, which includes the INR Coagulation Analyzer (Meter) and PT/INR Test Strips, is for the determination of International Normalized Ratio (INR) for the monitoring of oral anticoagulation therapy with Warfarin (a vitamin K antagonist) in fresh capillary whole blood from a fingerstick. The results are reported in INR as well as in seconds. It is intended to be used to monitor patients 18 years of age or older who are stable on vitamin K antagonist therapy for at least six weeks and is not intended for use in patients who are transitioning from heparin treatment to vitamin K antagonist therapy. The Xprecia Prime™ Coagulation System is an in-vitro diagnostic device intended for multi-patient use in professional healthcare settings including CLIA Waived and Point of care settings.

Recalls

DateFirmReason
2025-03-06Fisher DiagnosticsThe incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.
2025-03-06Fisher DiagnosticsThe incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.
2022-05-25Mckesson Medical-Surgical Inc. Corporate OfficeFacility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 0
2022-04-08Instrumentation LaboratoryVariable and out of specification QC results with HemosIL ReadiPlasTin. IL will remove all lots from the market and convert customers to an alternative prothrombin time (PT) reage
2021-10-13Instrumentation LaboratoryThe firm has received customer reports of performance issues with the affected lot, including increased imprecision, out of range quality controls, and prolonged sample results. If
2020-12-02Roche Diagnostics Operations, Inc.Possible Misinterpretation of Displayed Measuring Units from INR to %Quick or Seconds; providing instructions to users for ensuring the meter is displaying INR results
2020-12-02Roche Diagnostics Operations, Inc.Possible Misinterpretation of Displayed Measuring Units from INR to %Quick or Seconds; providing instructions to users for ensuring the meter is displaying INR results
2018-12-20TERRIFIC CARE LLCPotential for abnormally high INR test results with the CoaguChek XS PT Test Strips for customers who purchased products directly from Terrific Care LLC dba MedEx Supply via websi
2018-09-13Roche Diagnostics CorporationAbnormally high INR test results with the affected CoaguChek test strips
2018-08-01Instrumentation Laboratory Co.There is a potential for increased imprecision, out of range quality controls and prolonged sample results.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.